BioInvent International AB (BINV.ST) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Sweden · ISIN SE0015244520
BioInvent International AB financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 44.69 m SEK | 226.50 m SEK |
| Gross profit | 44.69 m SEK | 226.50 m SEK |
| Operating income | -471.06 m SEK | -351.39 m SEK |
| EBIT | -428.69 m SEK | -351.39 m SEK |
| Net income | -429.38 m SEK | -332.86 m SEK |
| Diluted EPS – continuing operations | -6.53 SEK | -5.06 SEK |
Full history since 2000, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About BioInvent International AB
BioInvent International AB (publ), a clinical-stage company, discovers and develops immuno-modulatory antibodies for cancer therapy in Sweden, Europe, the United States, and internationally. The company's drug candidates include BI-1808, an anti- tumor necrosis factor receptor-2 (TNFR2) antibody in Phase 2a trial for the treatment of solid tumors and T-cell lymphoma; BI-1206, an anti-FcyRIIB antibody in Phase 2a trial for the treatment of non-Hodgkin's lymphoma, and solid tumors; BI-1910, an anti-TNFR2 antibody in Phase 1/2a clinical trial to treat solid tumors; BI-1607, an anti-FcyRIIB antibody in Phase 1b/2a clinical trial to treat solid tumors; and BT-001, an anti- cytotoxic T lymphocyte-associated protein-4 (CTLA-4) antibody in Phase 1/2a clinical trial for the treatment of solid tumors. It has a collaboration with Transgene oncolytic virus platform with BioInvent proprietary antibodies; MSD to evaluate BI-1808, BI-1910, BI-1206, BI-1607, and BT-001 in combination with Keytruda; CASI Pharmaceuticals to develop BI-1206 in both hematological and solid cancers; AstraZeneca to evaluate BI-1206 in combination with rituximab and Calquence; and XOMA. BioInvent International AB (publ) was incorporated in 1996 and is based in Lund, Sweden.
More stocks
- FRANKLIN WIRELESS CORP (FKWL)
- Coronado Global Resources Inc. (CODQL)
- Blaize Holdings, Inc. (BZAI)
- HWH International Inc. (HWH)
- SELECTIS HEALTH, INC. (GBCS)
- CareView Communications Inc (CRVW)
- Brilliant Earth Group, Inc. (BRLT)
- DocGo Inc. (DCGO)
- DSwiss Inc (DQWS)
- Cytosorbents Corp (CTSO)
- Annovis Bio, Inc. (ANVS)
- CVRx, Inc. (CVRX)
Not investment advice. All data without warranty, price as of 18.11.2026. Details in the risk notice.